Da Er Kang Capsule Treatment Phlegm Stagnation Epilepsy Clinical Efficacy

Objective:This topic by observing DAerkang capsule clinical efficacy phlegm stagnation type of epilepsy,To further affirmed Chinese medicine treatment has obvious advantages in epilepsy provide clinical basis.Methods:All cases were the subject of consciousness from Heilongjiang shenzhi hospital patients, according to uniform diagnostic criteria, inclusion criteria, exclusion criteria identified60cases of qualified subjects were randomly divided into treatment group and control group,30cases in each. DAerkang capsule for oral therapy in treatment group and control group was treated with risperidone Tablets, both groups while using repetitive transcranial magnetic stimulation rTMS therapy for8weeks. Using fixed-type scale for general information, clinical history of collecting, using Brief Psychiatric Rating Scale (BPRS), negative symptoms of schizophrenia Scale (SANS) conducted before and after treatment efficacy.Results:1After treatment, the BPRS and SANS scores with each of the groups before treatment significantly reduced after treatment BPRS scores showed no statistically significant (P>0.05), after treatment table SANS score difference statistically significant (P<0.05).2The total effective rate was86.67%in the control group, the total effective rate was63.33%, the efficiency of the two groups was significant difference (P<0.05) statistically.3to TESS rating scale adverse drug reactions, the two groups were significantly different (P<0.01) statistically.Conclusion:DAerkang capsule treatment phlegm stagnation epilepsy is effective, and no adverse reactions during clinical trials occurred table informed DAerkang capsule is an effective prescription treatment of this disease.